Nutrients for Better Mental Performance

Nutrients for Better Mental Performance

This is a great video by Google Tech Talks presented by Steven Wm. Fowkes., he goes into detail explaining how different nutrition’s can help people of all ages treat various physical and mental conditions, spanning from genetic disorders such as Down syndrome, to adolescent behavior problems and on to senility and Alzheimer’s disease in the elderly. 

He will also speak about using nutrients to address memory problems as well as verbal and multi-tasking challenges that the testosterone-poised homo sapiens (i.e., men) are commonly known for.

ABSTRACT

Presented by Steven Wm. Fowkes.

The talk will answer questions like:

1. Which nutrients promote optimal brain function?
2. What nutrients are commonly deficient enough to impair mental performance?
3. How can you get a better nights sleep without Ambien?
4. What nutrients counteract aspects of aging?
5. Is there an alternative to serotonin reuptake inhibitor (SRI) antidepressants?
6. What modern nutrition myths lead us to consume products that sabotage healthy brain function?
7. What tests can you get from your doctor?
8. What nutrients affect appetite, alertness, and tension?
9. What nutrient combo will prevent hangovers 90% of the time?

Molecular Link between the Active Component of Marijuana and Alzheimer’s Disease Pathology

http://pubs.acs.org/doi/abs/10.1021/mp060066m

Marijuana and Alzheimer’s Disease

“Alzheimer’s disease is the leading cause of dementia among the elderly, and with the ever-increasing size of this population, cases of Alzheimer’s disease are expected to triple over the next 50 years. Consequently, the development of treatments that slow or halt the disease progression have become imperative to both improve the quality of life for patients and reduce the health care costs attributable to Alzheimer’s disease. Here, we demonstrate that the active component of marijuana, Δ⁹-tetrahydrocannabinol (THC), competitively inhibits the enzyme acetylcholinesterase (AChE) as well as prevents AChE-induced amyloid β-peptide (Aβ) aggregation, the key pathological marker of Alzheimer’s disease. Computational modeling of the THC−AChE interaction revealed that THC binds in the peripheral anionic site of AChE, the critical region involved in amyloidgenesis. Compared to currently approved drugs prescribed for the treatment of Alzheimer’s disease, THC is a considerably superior inhibitor of Aβ aggregation, and this study provides a previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.”